Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer
← catalyst calendarSponsored by Corcept Therapeutics (industry) · CORT — their whole pipeline →. With Gynecologic Oncology Group.
Phase
Phase 3
Status
Active, not recruiting
Study type
Interventional
Design
Randomized · None · Treatment
Enrollment
381actual
Sites
117
Countries
Argentina, Australia, Belgium +11
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2022-06-29 | actual | When the study began enrolling |
| Primary completion | 2025-03-24 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Mar 2026 | estimated | The whole study's end, after follow-up |
| First posted | 2022-02-25 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-04-16 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Ovarian Neoplasm
- Fallopian Tube Neoplasms
- Peritoneal Neoplasms
Interventions
- Drug: Nab-paclitaxel 80 mg/m^2
- Drug: Relacorilant 150 mg once daily (QD)
- Drug: Nab-paclitaxel 100 mg/m^2
Primary outcomes
what the primary-completion date above is the date OFProgression-free Survival as Assessed by BICR
measured Up to 24 months from enrollment of the last patient
Overall survival
measured Up to 24 months from enrollment of the last patient
Publications
- PMID 41974149 — linked by the registry
- PMID 40473448 — linked by the registry
- PMID 39032926 — linked by the registry
- PMID 37364223 — linked by the registry
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · CORT's whole pipeline · Catalyst calendar · Every registered study · What changed